ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,011, issued on Feb. 4, was assigned to Sylvain Tourel (Hattingen, Germany).
"Selective cell death-inducing enzyme system" was invented by Sylvain Tourel (Hattingen, Germany) and Tabea Kraft (Dortmund, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a fusion protein containing a selective cell death-inducing enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use."
The patent was filed on March 13, 2018, under Application No. 16/493,605.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser...